Rbm24, an RNA-binding Protein and a Target of p53, Regulates p21 Expression via mRNA Stability

Journal of Biological Chemistry

Volumn 289, Issue 6, 2014, Pages 3164-3175

  Jiang, Yuqian ^a   Zhang, Min ^a   Qian, Yingjuan ^a   Xu, Enshun ^a   Zhang, Jin ^a   Chen, Xinbin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER BIOLOGY; CELL CYCLE; MRNA DECAY; P53; RNA-BINDING PROTEIN;

3' UNTRANSLATED REGIONS; AMINO ACID MOTIFS; CELL CYCLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION; HUMANS; RNA STABILITY; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84893698618     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.524413     Document Type: Article

References (42)

1. Vogelstein, B., Lane, D., and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-310
2. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825
3. Jeffers, J. R., Parganas, E., Lee, Y., Yang, C., Wang, J., Brennan, J., MacLean, K. H., Han, J., Chittenden, T., Ihle, J. N., McKinnon, P. J., Cleveland, J. L., and Zambetti, G. P. (2003) Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4, 321-328
4. Qian, Y., Zhang, J., Yan, B., and Chen, X. (2008) DEC1, a basic helix-loophelix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence. J. Biol. Chem. 283, 2896-2905
5. el-Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., and Wang, Y. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54, 1169-1174
6. Kiledjian, M., Wang, X., and Liebhaber, S. A. (1995) Identification of two KHdomain proteins in the-globinmRNPstability complex.EMBOJ. 14, 4357-4364
7. Collier, B., Goobar-Larsson, L., Sokolowski, M., and Schwartz, S. (1998) J. Biol. Chem. 273, 22648-22656
8. Krecic, A. M., and Swanson, M. S. (1999) hnRNP complexes: composition, structure, and function. Curr. Opin. Cell Biol. 11, 363-371
9. Wurth, L. (2012) Versatility of RNA-binding proteins in cancer. Comp. Funct. Genomics 2012, 178525
10. Carvalho, B., Postma, C., Mongera, S., Hopmans, E., Diskin, S., van de Wiel, M. A., van Criekinge, W., Thas, O., Matthäi, A., Cuesta, M. A., Terhaar Sive Droste, J. S., Craanen, M., Schröck, E., Ylstra, B., and Meijer, G. A. (2009) Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 58, 79-89
11. Hötte, G. J., Linam-Lennon, N., Reynolds, J. V., and Maher, S. G. (2012) Radiation sensitivity of esophageal adenocarcinoma: the contribution of the RNA-binding protein RNPC1 and p21-mediated cell cycle arrest to radioresistance. Radiat. Res. 177, 272-279
12. Zhang, J., Cho, S. J., Shu, L., Yan, W., Guerrero, T., Kent, M., Skorupski, K., Chen, H., and Chen, X. (2011) Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas. Genes Dev. 25, 1528-1543
13. Shu, L., Yan, W., and Chen, X. (2006) RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript. Genes Dev. 20, 2961-2972
14. Cho, S. J., Zhang, J., and Chen, X. (2010) RNPC1 modulates the RNAbinding activity of, and cooperates with, HuR to regulate p21 mRNA stability. Nucleic Acids Res. 38, 2256-2267
15. Miyamoto, S., Hidaka, K., Jin, D., and Morisaki, T. (2009) RNA-binding proteins Rbm38 and Rbm24 regulate myogenic differentiation via p21-dependent and -independent regulatory pathways. Genes Cells 14, 1241-1252
16. Maragh, S., Miller, R. A., Bessling, S. L., McGaughey, D. M., Wessels, M. W., de Graaf, B., Stone, E. A., Bertoli-Avella, A. M., Gearhart, J. D., Fisher, S., and McCallion, A. S. (2011) Identification ofRNAbinding motif proteins essential for cardiovascular development. BMC Dev. Biol. 11, 62
17. Poon, K. L., Tan, K. T., Wei, Y. Y., Ng, C. P., Colman, A., Korzh, V., and Xu, X. Q. (2012) RNA-binding protein RBM24 is required for sarcomere assembly and heart contractility. Cardiovasc. Res. 94, 418-427
18. Erhardt, J. A., and Pittman, R. N. (1998) Ectopic p21WAF1 expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment. J. Biol. Chem. 273, 23517-23523
19. Dulić, V., Drullinger, L. F., Lees, E., Reed, S. I., and Stein, G. H. (1993) Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc. Natl. Acad. Sci. U.S.A. 90, 11034-11038
20. Wang, Y., Blandino, G., and Givol, D. (1999) Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin. Oncogene 18, 2643-2649
21. Jung, Y. S., Qian, Y., and Chen, X. (2010) Examination of the expanding pathways for the regulation of p21 expression and activity. Cell. Signal. 22, 1003-1012
22. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F., and Caput, D. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90, 809-819
23. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., and McKeon, F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2, 305-316
24. Zhu, J., Jiang, J., Zhou, W., and Chen, X. (1998) The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 58, 5061-5065
25. Joseph, B., Orlian, M., and Furneaux, H. (1998) p21waf1 mRNA contains a conserved element in its 3-untranslated region that is bound by the Elav like mRNA-stabilizing proteins. J. Biol. Chem. 273, 20511-20516
26. Wang, W., Furneaux, H., Cheng, H., Caldwell, M. C., Hutter, D., Liu, Y., Holbrook, N., and Gorospe, M. (2000) HuR regulates p21 mRNA stabilization by UV light. Mol. Cell. Biol. 20, 760-769
27. Yang, X., Wang, W., Fan, J., Lal, A., Yang, D., Cheng, H., and Gorospe, M. (2004) Prostaglandin A2-mediated stabilization of p21 mRNA through an ERK-dependent pathway requiring the RNA-binding protein HuR. J. Biol. Chem. 279, 49298-49306
28. Scoumanne, A., Cho, S. J., Zhang, J., and Chen, X. (2011) The cyclin-dependent kinase inhibitor p21 is regulated by RNA-binding protein PCBP4 via mRNA stability. Nucleic Acids Res. 39, 213-224
29. Waggoner, S. A., Johannes, G. J., and Liebhaber, S. A. (2009) Depletion of the poly(C)-binding proteins-CP1 and-CP2 from K562 cells leads to p53-independent induction of cyclin-dependent kinase inhibitor (CDKN1A) and G1 arrest. J. Biol. Chem. 284, 9039-9049
30. Johansen, F. E., and Prywes, R. (1994) Two pathways for serum regulation of the c-fos serum response element require specific sequence elements and a minimal domain of serum response factor. Mol. Cell. Biol. 14, 5920-5928
31. Chen, X., Zhang, J., Zhang, M., Liu, S., Yan, W., and Jung, J. (2012) Serine 123 phosphorylation modulates p21 protein stability and activity by suppressing ubiquitin-independent proteasomal degradation. J. Biol. Chem. 287, 34410-34418
32. Chen, X., Bargonetti, J., and Prives, C. (1995) p53, through p21WAF1/CIP1, induces cyclin D1 synthesis. Cancer Res. 55, 4257-4263
33. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., and Vogelstein, B. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501
34. Waldman, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. (1996) Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713-716
35. Liu, G., and Chen, X. (2006) DNA polymerase-, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates theDNA damage checkpoint and p53 activation. Mol. Cell. Biol. 26, 1398-1413
36. Dohn, M., Nozell, S., Willis, A., and Chen, X. (2003) Tumor suppressor gene-inducible cell lines. Methods Mol. Biol. 223, 221-235
37. Xu, E., Zhang, J., and Chen, X. (2013) MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability. Oncogene 32, 2169-2178
38. Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., Fotouhi, N., and Liu, E. A. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844-848
39. Zhang, J., and Chen, X. (2008) Posttranscriptional regulation of p53 and its targets by RNA-binding proteins. Curr. Mol. Med. 8, 845-849
40. Cléry, A., Blatter, M., and Allain, F. H. (2008) RNA recognition motifs: boring? Not quite. Curr. Opin. Struct. Biol. 18, 290-298
41. Collins, K., Jacks, T., and Pavletich, N. P. (1997) The cell cycle and cancer. Proc. Natl. Acad. Sci. U.S.A. 94, 2776-2778
42. Vogelstein, B., and Kinzler, K. W. (2004) Cancer genes and the pathways they control. Nat. Med. 10, 789-799